Literature DB >> 11874399

The influence of body weight on the pharmacokinetics of mefloquine.

J A SImpson, L Aarons, R Price, N J White.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11874399      PMCID： PMC1874313          DOI： 10.1046/j.0306-5251.2001.01561.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  Nonlinear mixed effects models for repeated measures data.

Authors:  M L Lindstrom; D M Bates
Journal:  Biometrics       Date:  1990-09       Impact factor: 2.571

2.  Quantitation of Fansimef components (mefloquine + sulfadoxine + pyrimethamine) in human plasma by two high-performance liquid chromatographic methods.

Authors:  M D Edstein; I D Lika; T Chongsuphajaisiddhi; A Sabchareon; H K Webster
Journal:  Ther Drug Monit       Date:  1991-03       Impact factor: 3.681

3.  Population pharmacokinetics of mefloquine in patients with acute falciparum malaria.

Authors:  J A Simpson; R Price; F ter Kuile; P Teja-Isavatharm; F Nosten; T Chongsuphajaisiddhi; S Looareesuwan; L Aarons; N J White
Journal:  Clin Pharmacol Ther       Date:  1999-11       Impact factor: 6.875

Review 4.  Clinical pharmacokinetics of mefloquine.

Authors:  J Karbwang; N J White
Journal:  Clin Pharmacokinet       Date:  1990-10       Impact factor: 6.447

5.  Mefloquine pharmacokinetics and resistance in children with acute falciparum malaria.

Authors:  F Nosten; F ter Kuile; T Chongsuphajaisiddhi; K Na Bangchang; J Karbwang; N J White
Journal:  Br J Clin Pharmacol       Date:  1991-05       Impact factor: 4.335
  5 in total
  2 in total

1.  Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria.

Authors:  Elizabeth A Ashley; Kasia Stepniewska; Niklas Lindegårdh; Rose McGready; Robert Hutagalung; Rae Hae; Pratap Singhasivanon; Nicholas J White; François Nosten
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

2.  Compliance with a three-day course of artesunate-mefloquine combination and baseline anti-malarial treatment in an area of Thailand with highly multidrug resistant falciparum malaria.

Authors:  Kanungnit Congpuong; Pongwit Bualombai; Vick Banmairuroi; Kesara Na-Bangchang
Journal:  Malar J       Date:  2010-02-04       Impact factor: 2.979
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.